Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T89 (Dantonic) for Acute Mountain Sickness
NCT04993729Phase 3Completed
- Sponsor
- Tasly Group
- Start
- Jul 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of Compound Danshen in acute mountain sickness (AMS), sponsored by Tasly Group. Started Jul 2021; status: completed.
02
Drugs
Compound Danshen
03
Conditions
acute mountain sickness (AMS)
Beyond the preview
Go deeper on NCT04993729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04993729.